Abstract Coronavirus disease 2019 (COVID-19) has emerged as a pandemic at the end of
2019 and continues to exert an unfavorable worldwide health impact on a large proportion …

Abstract Background Coronavirus disease 2019 (COVID‐19) is associated with
coagulopathy but the optimal prophylactic anticoagulation therapy remains uncertain and …

Soon after the outbreak of coronavirus disease 2019 (COVID-19), unexplained sustained
fatigue, cognitive disturbance, and muscle ache/weakness were reported in patients who …

Background It is uncertain whether higher doses of anticoagulants than recommended for
thromboprophylaxis are necessary in COVID‐19 patients hospitalized in general wards …

Background Patients with COVID-19 infection are commonly reported to have an increased
risk of venous thrombosis. The choice of anti-thrombotic agents and doses are currently …

Background Anticoagulation in hospitalized COVID-19 patients has been associated with
survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The …

A proportion of people infected with SARS-CoV-2 develop moderate or severe COVID-19,
with an increased risk of thromboembolic complications. The inflammatory response to …

Many high-income countries and international institutions have bet the proverbial farm on
the quick development of a vaccine to respond to the Covid-19 pandemic, implementing …

Abstract Chimamanda Ngozi Adichie showed how a single story is limited and thereby
distorts the true nature of an issue. During this COVID‐19 pandemic there have been, at …

The Coronavirus Disease 2019 (COVID-19) pandemic has resulted in significant morbidity
and mortality worldwide. Although initial reports concentrated on severe respiratory illness …